Highlights | Novo Nordisk reported lower-than-expected sales of its popular weight-loss drug Wegory, raising concerns about rising competition from Eli Lilly
Currency:DKKAug 7, 2024
Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
Revenue | 68.56B | 68.06B | -503.19M |
Miss Est. | +26.27% | +25.34% | -0.73% |
EPS | 5.01 | 4.49 | -0.52 |
Miss Est. | +16.19% | +3.94% | -10.45% |
Oct 1, 2024
Revenue
EPS
EBIT
Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: DKK
Unlock Free Earnings Estimates
Read more
No Data
No Data